NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Luson BioVentures

Luson BioVentures

Indianapolis, Indianalusonbioventures.com

Overview

Luson BioVentures is a venture capital investment firm that focuses on the creation and development of biotechnology and pharmaceutical companies. The firm has a particular focus on mental health, neuroscience, and drug discovery. Its strategy involves building companies with experienced executives and using a capital-efficient virtual or quasi-virtual business model.

Portfolio Companies

2

Investments

Luson BioVentures investments
CompanyDateStageLead
Gate NeurosciencesMay 2025M&ACo-investor
Syndeio BiosciencesMay 2025VC RoundCo-investor
Syndeio BiosciencesOct 2022VC RoundCo-investor
Gate NeurosciencesSep 2022Convertible DebtCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersIndianapolis, Indiana
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.